HLB Co., Ltd.
028300
Rank in Stocks
#4137
HLB Co., Ltd. operates in two distinct sectors: pharmaceutical production and... HLB Co., Ltd. operates in two distinct sectors: pharmaceutical production and naval construction. In South Korea, its maritime division produces and distributes a diverse range of lifeboats, catering to offshore platforms, drilling vessels, and passenger cruise liners. Its offerings include traditional, free-fall, and rescue boat designs. Beyond lifeboats, HLB's product portfolio extends to marine and yacht engines, hooks, and a variety of specialized vessels such as rigid inflatable (RIB), patrol, fishing, aluminum, and leisure boats, as well as fishery inspection ships and general safety equipment. The company further offers comprehensive support services, including inspection and repair of lifeboats and davits, service engineering training, and the provision of spare parts. On the pharmaceutical front, HLB is engaged in the development of Riboseranib, a targeted anti-cancer agent, and Apilia, a treatment specifically for ovarian cancer. Established in 1975, HLB Co., Ltd. is headquartered in Ulsan, South Korea.
Share Price
$29.56
Market Cap
$3.93B
Change (1 day)
-0.47%
Change (1 year)
-7.59%
Country
KR
Trade HLB Co., Ltd. (028300)
Category
Healthcare
Number of shares outstanding for HLB Co., Ltd. (028300)
Number of shares outstanding as of June 2026: 132.90M
According to HLB Co., Ltd. latest financial reports and stock price the company's current number of shares outstanding is 132.90M. At the end of December 2023 the company had 121.24M shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for HLB Co., Ltd. (028300) from 2012 to 2026
Shares Outstanding at the end of each year
| Year | Shares Outstanding | Change |
|---|---|---|
| 2026 (TTM) | 132.90M | 1.68% |
| 2024 | 130.70M | 7.81% |
| 2023 | 121.24M | 7.68% |
| 2022 | 112.59M | -6.32% |
| 2021 | 120.18M | -2.83% |
| 2020 | 123.68M | 22.11% |
| 2019 | 101.28M | 6.04% |
| 2018 | 95.51M | 4.49% |
| 2017 | 91.40M | 0.94% |
| 2016 | 90.55M | 7.76% |
| 2015 | 84.04M | 34.50% |
| 2014 | 62.48M | 7.44% |
| 2013 | 58.16M | 20.89% |
| 2012 | 48.11M | 0.00% |
Shares Outstanding for similar companies or competitors
| Company | Shares Outstanding | Difference | Country |
|---|---|---|---|
| 253.90M | 91.04% |
US
|
|
| 396.00M | 197.96% |
US
|
|
| 478.91M | 260.35% |
AU
|
|
| - | - |
CH
|
|
| 62.19M | -53.21% |
NL
|
